Navicixizumab

Please request pricing for this article.
Request Pricing

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T76871-5mg	5 mg				7 - 10 business days*		-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory... more

Close menu

Product information "Navicixizumab"

Description: Navicixizumab (OMP-305B83) is a bispecific anti-VEGF and anti-DLL4 inhibitory antibody that can be combined with Paclitaxel for cancer research, particularly in studies of ovarian, primary peritoneal, or fallopian tube cancer [1] [2] [3].

Supplier:	TargetMol
Supplier-Nr:	T76871

Properties

Application:	Targets delta (DLL)
Conjugate:	No

Database Information

CAS :	1638338-43-8\| Matching products
KEGG ID :	K05448 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Navicixizumab"

Write a review